Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...

FDA Commissioner Marty Makary, MD, MPH, announced that George Tidmarsh, MD, PhD, a cancer and pediatric specialist, will ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

Nearly half of women in the U.S. going through menopause may experience moderate to severe vasomotor symptoms due to ...

The European Commission has granted marketing authorization in the European Union (EU) for German pharma major Bayer’s Nubeqa ...

Doctors now recognize the need to approach testosterone deficiency with the same clinical rigour as other hormone ...

A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra® for men - in a proprietary topical formulation demonstrated to work where women need it most SAN DIEGO, July ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Children’s National Hospital will stop prescribing gender-affirming medication, citing “escalating legal and regulatory risks ...